OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BRIB57

Bright Brothers Ltd

Commodity ChemicalsVerified

Bright Brothers operates with a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.13, suggesting it has just enough current assets to cover its current liabilities. The company's return on equity (ROE) is 11.12%, which is a strong indicator of its ability to generate profits from shareholders' equity. The company's profitability is reflected in its return on assets (ROA) of 3.68%, which is a measure of how efficiently it uses its assets to generate earnings. This ROA is in line with the industry's preferred metrics, which emphasize asset efficiency and operational leverage. The operating margin, calculated as operating income divided by revenue, is 5.38%, which is a key performance indicator for the company's core operations. Bright Brothers' revenue is primarily derived from the manufacturing of injection molded plastics products for consumer durable industry and the marketing of material handling crates. The company's geographic exposure is concentrated in India, with no significant international operations disclosed. The company's revenue concentration in a single country may expose it to local economic and regulatory risks. The company's growth trajectory is expected to be modest, with the outlook for the current fiscal year (FY) and the next FY indicating a slight increase in revenue. The capital expenditure for the latest period was negative at -110,353,000 INR, suggesting a reduction in investment in new assets. The company's free cash flow of 74,582,000 INR indicates that it has sufficient cash to fund operations and potentially return value to shareholders. The risk assessment for Bright Brothers indicates a medium liquidity risk, with the company having a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's risk profile is further influenced by its exposure to the Indian market and the volatility of the plastics industry. Recent events, as disclosed in the latest financial filings, include the company's continued focus on its core manufacturing and marketing activities. The company has not disclosed any significant new projects or strategic initiatives in the latest period. The company's recent financial performance and strategic direction suggest a stable but not aggressive growth strategy.

30-day price · BRIB+40.15 (+19.7%)
Low$190.95High$292.90Close$243.85As of15 May, 00:00 UTC
Profile
CompanyBright Brothers Ltd
TickerBRIB.BO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Bright Brothers Limited is an India-based company engaged in the manufacturing of injection molded plastics products for original equipment manufacturers in the consumer durable industry and the marketing of its own products under the Brite brand for material handling crates.

Classification. Bright Brothers is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

Bright Brothers operates with a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.13, suggesting it has just enough current assets to cover its current liabilities. The company's return on equity (ROE) is 11.12%, which is a strong indicator of its ability to generate profits from shareholders' equity. The company's profitability is reflected in its return on assets (ROA) of 3.68%, which is a measure of how efficiently it uses its assets to generate earnings. This ROA is in line with the industry's preferred metrics, which emphasize asset efficiency and operational leverage. The operating margin, calculated as operating income divided by revenue, is 5.38%, which is a key performance indicator for the company's core operations. Bright Brothers' revenue is primarily derived from the manufacturing of injection molded plastics products for consumer durable industry and the marketing of material handling crates. The company's geographic exposure is concentrated in India, with no significant international operations disclosed. The company's revenue concentration in a single country may expose it to local economic and regulatory risks. The company's growth trajectory is expected to be modest, with the outlook for the current fiscal year (FY) and the next FY indicating a slight increase in revenue. The capital expenditure for the latest period was negative at -110,353,000 INR, suggesting a reduction in investment in new assets. The company's free cash flow of 74,582,000 INR indicates that it has sufficient cash to fund operations and potentially return value to shareholders. The risk assessment for Bright Brothers indicates a medium liquidity risk, with the company having a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's risk profile is further influenced by its exposure to the Indian market and the volatility of the plastics industry. Recent events, as disclosed in the latest financial filings, include the company's continued focus on its core manufacturing and marketing activities. The company has not disclosed any significant new projects or strategic initiatives in the latest period. The company's recent financial performance and strategic direction suggest a stable but not aggressive growth strategy.
Key takeaways
  • Bright Brothers has a moderate debt-to-equity ratio and a current ratio just above 1, indicating a balanced capital structure.
  • The company's ROE of 11.12% is strong, suggesting effective use of shareholders' equity.
  • The company's ROA of 3.68% is in line with industry metrics, indicating efficient asset utilization.
  • The company's revenue is concentrated in India, which may expose it to local market risks.
  • The company's free cash flow is positive, indicating the ability to fund operations and potentially return value to shareholders.
  • The company's growth trajectory is expected to be modest, with a focus on maintaining its current operations.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$3.36B
Gross profit$784.6M
Operating income$180.6M
Net income$84.9M
R&D
SG&A
D&A
SBC
Operating cash flow$111.9M
CapEx-$110.4M
Free cash flow$74.6M
Total assets$2.31B
Total liabilities$1.55B
Total equity$763.5M
Cash & equivalents
Long-term debt$544.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$763.5M
Net cash-$544.1M
Current ratio1.1
Debt/Equity0.7
ROA3.7%
ROE11.1%
Cash conversion1.3%
CapEx/Revenue-3.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricBRIBActivity
Op margin5.4%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.5%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin23.4%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity71.0%59.0% medp25 54.9% · p75 72.9%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 19:35 UTC#f81be32f
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 19:36 UTCJob: 2541ad2b